Abstract:Defects in DNA replication are implicated as early and causal events in malignancy. However, the immediate effects of impaired DNA replication licensing on cell cycle progression of non-malignant human cells are unknown. Therefore, we have investigated the acute effects of Mcm7 ablation using synchronized cultures of untransformed Human Dermal Fibroblasts (HDF). Mcm7 ablation elicited a G1 delay associated with impaired activation of CDK4 and CDK2 and reduced Rb phosphorylation. The cell cycle delay of Mcm7-ablated cells was not associated with a DNA damage response. However, levels of cyclin D1 mRNA were specifically reduced and binding of RNA Polymerase II to the CYCD1 promoter was decreased in Mcm7-depleted cells. Similar to Mcm7-deficiency, Mcm2- or Cdc6-depletion led to impaired cyclin D expression. Ectopic over-expression of Cdc6 in quiescent cells promoted cyclin D1 expression, CDK4 activation and G1 progression. Therefore timely and efficient expression of cyclin D1 during G1 phase requires replication licensing. Reconstitution of cyclin D1 expression was insufficient to correct the G1 delay of Mcm7-depleted cells, indicating that additional cell cycle events during G1are dependent on replication licensing. However, ectopic expression of the HPV-E7 oncoprotein, and the resulting bypass of the requirement for cyclin D1-Rb signaling enabled Mcm7-depleted cells to enter S-phase. HPV-E7-induced S-phase entry of Mcm7-depleted cells led to a DNA damage response, a hallmark of pre-malignancy. Taken together, our results suggest the existence of a 'replication licensing restriction point' that couples pre-RC assembly with G1 progression in normal cells to minimize replication stress, DNA damage and tumorigenesis.

D-type cyclins regulate DNA mismatch repair in the G1 and S phases of the cell cycle, maintaining genome stability

In my end is my beginning: control of end resection and DSBR pathway ‘choice’ by cyclin-dependent kinases

CDK-mediated RNF4 Phosphorylation Regulates Homologous Recombination in S-phase

DNA damage during S-phase mediates the proliferation-quiescence decision in the subsequent G1 via p21 expression

DNA Repair by Nonhomologous End Joining and Homologous Recombination During Cell Cycle in Human Cells

Cyclin F-EXO1 axis controls cell cycle-dependent execution of double-strand break repair

CDK9-55 guides the anaphase-promoting complex/cyclosome (APC/C) in choosing the DNA repair pathway choice

The mitotic CIP2A-TOPBP1 axis facilitates mitotic pathway choice between MiDAS and MMEJ

Replication Licensing Promotes Cyclin D1 Expression and G1progression in Untransformed Human Cells

A role for homologous recombination proteins in cell cycle regulation

A Mitotic CDK5-PP4 Phospho-Signaling Cascade Primes 53BP1 for DNA Repair in G1.

P130/p107/p105rb-Dependent Transcriptional Repression During DNA-damage-induced Cell-Cycle Exit at G2

Effective mismatch repair depends on timely control of PCNA retention on DNA by the Elg1 complex

BRCA2 associates with MCM10 to suppress PRIMPOL-mediated repriming and single-stranded gap formation after DNA damage

AMBRA1 regulates cyclin D to guard S-phase entry and genomic integrity

The Mismatch Repair System is Required for S-phase Checkpoint Activation

DNA Damage Response is Suppressed by the High Cyclin-dependent Kinase 1 Activity in Mitotic Mammalian Cells

A cell cycle-dependent BRCA1–UHRF1 cascade regulates DNA double-strand break repair pathway choice

CDK-mediated Yku80 Phosphorylation Regulates the Balance Between Non-homologous End Joining (NHEJ) and Homologous Directed Recombination (HDR)

Dbf4-dependent kinase promotes cell cycle controlled resection of DNA double-strand breaks and repair by homologous recombination

Cdc14A and Cdc14B Redundantly Regulate DNA Double-Strand Break Repair